Showing results (111-120 of 151) with videos related to

Sort By:
Pageof 16
Emerging Infectious Diseases|January 26, 2022
SARS-CoV-2 Period Seroprevalence and Related Factors, Hillsborough County, Florida, USA, October 2020-March 2021Anna R Giuliano, Shari Pilon-Thomas, Michael J Schell, et al.
JAMA Oncology|March 10, 2022
Evaluation of Antibody Response to SARS-CoV-2 mRNA-1273 Vaccination in Patients With Cancer in FloridaAnna R Giuliano, Jeffrey E Lancet, Shari Pilon-Thomas, et al.
Frontiers in Oncology|March 20, 2018
Combination of Ipilimumab and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic MelanomaJohn E Mullinax, MacLean Hall, Sangeetha Prabhakaran, et al.
Molecular Cancer Therapeutics|June 24, 2025
PV-10 triggers immunogenic cell death in head and neck squamous cell carcinoma via endoplasmic reticulum stress and apoptosisSowjanya Thatikonda, Ritu Chaudhary, Yeva Meshkovska, et al.
Oncoimmunology|September 20, 2018
Expansion of tumor infiltrating lymphocytes (TIL) from bladder cancerMichael Poch, MacLean Hall, Autumn Joerger, et al.
Molecular Cancer Therapeutics|April 24, 2024
First-in-Human Stage III/IV Melanoma Clinical Trial of Immune Priming Agent IFx-Hu2.0Joseph Markowitz, Michael Shamblott, Andrew S Brohl, et al.
Nature Communications|August 19, 2020
T-cells produce acidic niches in lymph nodes to suppress their own effector functionsHao Wu, Veronica Estrella, Matthew Beatty, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2023
Paracrine enhancement of tumor cell proliferation provides indirect stroma-mediated chemoresistance via acceleration of tumor recovery between chemotherapy cyclesDaria Miroshnychenko, Tatiana Miti, Pragya Kumar, et al.
Cancer Research|October 4, 2023
Stroma-Mediated Breast Cancer Cell Proliferation Indirectly Drives Chemoresistance by Accelerating Tumor Recovery between Chemotherapy CyclesDaria Miroshnychenko, Tatiana Miti, Pragya Kumar, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 7, 2021
Th1 cytokine interferon gamma improves response in HER2 breast cancer by modulating the ubiquitin proteasomal pathwayYongsheng Jia, Krithika N Kodumudi, Ganesan Ramamoorthi, et al.
Pageof 16